First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

New England Journal of Medicine

Volumn 365, Issue 20, 2011, Pages 1863-1875

  Agnandji, Selidji Todagbe ^a,b   Lell, Bertrand ^a,b   Soulanoudjingar, Solange Solmeheim ^a,b   Fernandes, José Francisco ^a,b   Abossolo, Béatrice Peggy ^a,b   Conzelmann, Cornelia ^a,b   Methogo, Barbara Gaelle Nfono Ondo ^a,b   Doucka, Yannick ^a,b   Flamen, Arnaud ^a,b   Mordmüller, Benjamin ^a,b   Issifou, Saadou ^a,b   Kremsner, Peter Gottfried ^a,b   Sacarlal, Jahit ^c   Aide, Pedro ^c   Lanaspa, Miguel ^c   Aponte, John J ^c   Nhamuave, Arlindo ^c   Quelhas, Diana ^c   Bassat, Quique ^c   Mandjate, Sofia ^c   Macete, Eusébio ^c   Alonso, Pedro ^c   Abdulla, Salim ^d   Salim, Nahya ^d   Juma, Omar ^d   Shomari, Mwanajaa ^d   Shubis, Kafuruki ^d   Machera, Francisca ^d   Hamad, Ali Said ^d   Minja, Rose ^d   Mpina, Maxmillian ^d   Mtoro, Ali ^d   Sykes, Alma ^d   Ahmed, Saumu ^d   Urassa, Alwisa Martin ^d   Ali, Mohammed ^d   Mwangoka, Grace ^d   Tanner, Marcel ^d   Tinto, Halidou ^e   D'Alessandro, Umberto ^e   Sorgho, Hermann ^e   Valea, Innocent ^e   Tahita, Marc Christian ^e   Kaboré, William ^e   Ouédraogo, Sayouba ^e   Sandrine, Yara ^e   Guiguemdé, Robert Tinga ^e   Ouédraogo, Jean Bosco ^e   Hamel, Mary J ^f   Kariuki, Simon ^f   Odero, Chris ^f   Oneko, Martina ^f   Otieno, Kephas ^f   Awino, Norbert ^f   Omoto, Jackton ^f   Williamson, John ^f   Muturi Kioi, Vincent ^f   Laserson, Kayla F ^f   Slutsker, Laurence ^f   Otieno, Walter ^g   Otieno, Lucas ^g   Nekoye, Otsyula ^g   Gondi, Stacey ^g   Otieno, Allan ^g   Ogutu, Bernhards ^g   Wasuna, Ruth ^g   Owira, Victorine ^g   Jones, David ^g   Onyango, Agnes Akoth ^g   Njuguna, Patricia ^h   Chilengi, Roma ^h   Akoo, Pauline ^h   Kerubo, Christine ^h   Gitaka, Jesse ^h   Maingi, Charity ^h   Lang, Trudie ^h   Olotu, Ally ^h   Tsofa, Benjamin ^h   Bejon, Philip ^h   Peshu, Norbert ^h   Marsh, Kevin ^h   Owusu Agyei, Seth ⁱ   Asante, Kwaku Poku ⁱ   Osei Kwakye, Kingsley ⁱ   Boahen, Owusu ⁱ   Ayamba, Samuel ⁱ   Kayan, Kingsley ⁱ   Owusu Ofori, Ruth ⁱ   Dosoo, David ⁱ   Asante, Isaac ⁱ   Adjei, George ⁱ   Kwara, Evans ⁱ   Chandramohan, Daniel ⁱ   Greenwood, Brian ⁱ   Lusingu, John ^j   Gesase, Samwel ^j   Malabeja, Anangisye ^j   Abdul, Omari ^j   Kilavo, Hassan ^j   Mahende, Coline ^j   Liheluka, Edwin ^j   Lemnge, Martha ^j   Theander, Thor ^j   Drakeley, Chris ^j   Ansong, Daniel ^k   Agbenyega, Tsiri ^k   Adjei, Samuel ^k   Boateng, Harry Owusu ^k   Rettig, Theresa ^k   Bawa, John ^k   Sylverken, Justice ^k   Sambian, David ^k   Agyekum, Alex ^k   Owusu, Larko ^k   Martinson, Francis ^l   Hoffman, Irving ^l   Mvalo, Tisungane ^l   Kamthunzi, Portia ^l   Nkomo, Ruthendo ^l   Msika, Albans ^l   Jumbe, Allan ^l   Chome, Nelecy ^l   Nyakuipa, Dalitso ^l   Chintedza, Joseph ^l   Ballou, W Ripley ^m   Bruls, Myriam ^m   Cohen, Joe ^m   Guerra, Yolanda ^m   Jongert, Erik ^m   Lapierre, Didier ^m   Leach, Amanda ^m   Lievens, Marc ^m   Ofori Anyinam, Opokua ^m   Vekemans, Johan ^m   Carter, Terrell ⁿ   Leboulleux, Didier ⁿ   Loucq, Christian ⁿ   Radford, Afiya ⁿ   Savarese, Barbara ⁿ   Schellenberg, David ⁿ   Sillman, Marla ⁿ   Vansadia, Preeti ⁿ   more..

^a ALBERT SCHWEITZER HOSPITAL   (Gabon)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Ministérioda Saúde   (Mozambique)

^d IFAKARA HEALTH INSTITUTE   (Tanzania)

^e Institut de Recherche en Sciences de la Sante   (Burkina Faso)

^f KEMRI/CDC Research and Public Health Collaboration   (Kenya)

^g KEMRI Walter Reed Project   (Kenya)

^h KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

ⁱ Kintampo Health Research Center   (Ghana)

^j NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^k KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^l UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^m GSK   (Belgium)

ⁿ PATH Malaria Vaccine Initiative   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; MENINGOCOCCUS VACCINE; RABIES VACCINE;

AFRICA; AGE DISTRIBUTION; ANEMIA; ARTICLE; BRONCHIOLITIS; BRONCHITIS; BRONCHOPNEUMONIA; CHILD; CONTROLLED STUDY; CONVULSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FEBRILE CONVULSION; GASTROENTERITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGLYCEMIA; IMMUNOGENICITY; INCIDENCE; INFANT; INJECTION SITE REACTION; INTENTION TO TREAT ANALYSIS; KWASHIORKOR; MAJOR CLINICAL STUDY; MALARIA; MALNUTRITION; MENINGITIS; MYOSITIS; OTITIS MEDIA; PAIN; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALMONELLOSIS; SEIZURE; SEPSIS; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 81455154875     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1102287     Document Type: Article

References (27)

1. World malaria report: 2010. Geneva: World Health Organization, 2010.
2. Steketee RW, Campbell CC. Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects. Malar J 2010;9:299.
3. O'Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis 2010;10:545-55.
4. Alonso PL, Brown G, Arevalo-Herrera M, et al. A research agenda to underpin malaria eradication. PLoS Med 2011;8(1):e1000406.
5. Alonso PL, Sacarlal J, Aponte JJ, et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 2004;364:1411-20. (Pubitemid 39370716)
6. Bejon P, Lusingu J, Olotu A, et al. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 2008;359:2521-32.
7. Asante KP, Abdulla S, Agnandji S, et al. Safety and efficacy of the RTS,S/AS01(E) candidate malaria vaccine given with expanded-programme-on- immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis 2011;11:741-9.
8. Abdulla S, Oberholzer R, Juma O, et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 2008;359:2533-44.
9. Aponte JJ, Aide P, Renom M, et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007;370:1543-51. (Pubitemid 350018877)
10. Vekemans J, Leach A, Cohen J. Development of the RTS,S/AS malaria candidate vaccine. Vaccine 2009;27:Suppl 6:G67-G71.
11. Agnandji ST, Asante KP, Lyimo J, et al. Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. J Infect Dis 2010;202:1076-87.
12. Vekemans J, Marsh K, Greenwood B, et al. Assessment of severe malaria in a multicenter, phase III, RTS,S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care. Malar J 2011;10:221.
13. Swysen C, Vekemans J, Bruls M, et al. Development of standardized laboratory methods and quality processes for a phase III study of the RTS,S/AS01 candidate malaria vaccine. Malar J 2011;10:223.
14. Leach A, Vekemans J, Lievens M, et al. Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa. Malar J 2011;10:224.
15. Lievens M, Aponte JJ, Williamson J, et al. Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS,S/AS01 malaria vaccine in African children. Malar J 2011;10:222.
16. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidance for industry: E6 good clinical practice: consolidated guidance. April 1996:38-42, 50-8 (http://www.fda.gov/downloads/regulatoryinformation/guidances/ucm129515.pdf).
17. Bonhoeffer J, Menkes J, Gold MS, et al. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 2004;22:557-62. (Pubitemid 38114881)
18. Verbal autopsy standards: ascertaining and attributing cause of death. Geneva: World Health Organization, 2007.
19. Macete EV, Sacarlal J, Aponte JJ, et al. Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a phase I/IIb randomized double-blind bridging trial. Trials 2007;8:11.
20. MedDRA term selection: points to consider. ICH-endorsed guide for MedDRA users. Release 4.2. 2011:49 (http://www.ich.org/fileadmin/Public-Web-Site/ICH- Products/MedDRA/MedDRA-Documents/MedDRA-Term-Selection/Release-4.2-based-on-14. 1/TermSelection-PTC-R4.2-October2011.pdf).
21. Bojang KA, Milligan PJ, Pinder M, et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 2001;358:1927-34. (Pubitemid 34072872)
22. Guinovart C, Aponte JJ, Sacarlal J, et al. Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children. PLoS ONE 2009;4(4):e5165.
23. Sacarlal J, Aide P, Aponte JJ, et al. Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J Infect Dis 2009;200:329-36.
24. Olotu A, Lusingu J, Leach A, et al. Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial. Lancet Infect Dis 2011;11:102-9.
25. Aide P, Aponte JJ, Renom M, et al. Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial. PLoS One 2010;5(11):e13838.
26. White MT, Griffin JT, Drakeley CJ, Ghani AC. Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malar J 2010;9:82.
27. Greenwood BM, Bojang K, Whitty CJ, Targett GA. Malaria. Lancet 2005;365:1487-98. (Pubitemid 40591695)